Category: Regulatory/FDA

CHC_general1

08/20/2018

FDA Studying Extent of Risk Information in DTC Print Ads

CHC_offLabel

08/13/2018

FDA Finalizing Study of Disclosure Effectiveness in Drug Promotion

CHC_FDA-Regulatory Images1

07/31/2018

FDA Cracks Down on Deceptive Claims for “Vaginal Rejuvenation” Procedures

CHC_general1

07/11/2018

Exhibit Booth and Webpage Misbrand IND, OPDP Says in Enforcement Letter

CHC_FDA-Regulatory Images1

07/02/2018

False/Misleading Risk, Efficacy Claims in Online Video Cited in OPDP Enforcement Letter to Pfizer

CHC_FDA-Regulatory Images1

06/14/2018

FDA Final Guidance Documents on Communication Issues Improve Clarity

CHC_general1

05/04/2018

White House Drug Pricing Initiative Could Include Moves on Generics/Biosimilars, Demonstration Projects and an End to Part D Rebates, Rawson Says

CHC_general2

03/26/2018

FDA Announces Mobile App to Help Consumers Get Drug Info

CHC_DTCadvertisement1

03/14/2018

FDA Ramps Up Drug Promotion Research Focus